When budgets are tight, there are better options than colonoscopies for colorectal cancer screening

Health Affairs

Volumn 29, Issue 9, 2010, Pages 1734-1740

  Subramanian, Sujha ^a   Bobashev, Georgiy ^a   Morris, Robert J ^a  

^a RTI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUAIAC;

ARTICLE; BARIUM ENEMA; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; HEALTH CARE COST; HUMAN; IMMUNOCHEMISTRY; INTERMETHOD COMPARISON; MEDICAID; MEDICAL PRACTICE; MEDICARE; OCCULT BLOOD TEST; PRACTICE GUIDELINE; QUALITY ADJUSTED LIFE YEAR; REIMBURSEMENT; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SIGMOIDOSCOPY;

BUDGETS; COLONOSCOPY; COLORECTAL NEOPLASMS; COMPUTER SIMULATION; COST-BENEFIT ANALYSIS; GUIDELINES AS TOPIC; HUMANS; OCCULT BLOOD; QUALITY OF LIFE;

EID: 81755177907     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.2008.0898     Document Type: Article

References (29)

1. Rex DK, Johnson DA, Lieberman DA, Burt RW, Sonnenberg A. Colorectal cancer prevention: screening recommendations of the American College of Gastroenterology. Am J Gastroenterol. 2000;95:868-77.
2. Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale; update based on new evidence. Gastroenterology. 2003;124:544-60.
3. Shapiro JA, Seeff LC, Thompson TD, Nadel MR, Klabunde CN, Vernon SW, et al. Colorectal cancer test use from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev. 2008;17:1623-30.
4. National Governors Association, Center for Best Practices. State strategies for curbing colorectal cancer [Internet]. Washington (DC): NGA; 2008 Jun 3 [cited 2008 Oct 22]. Available from: http:// www.nga.org/Files/pdf/ 0806CURBCANCER.PDF
5. Whitlock EP, Lin JS, Liles E, Beil TL, Fu R. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149:638-58.
6. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. CA Cancer J Clin. 2003;53:27-43.
7. Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997;112:594-64.
8. Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, Bond J, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the U.S. Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008;58(3):130-60.
9. Chen X, White MC, Pepins LA, Seeff LC. Increase in screening for colorectal cancer in older Americans: results from a national survey. J Am Geriatr Soc. 2008;56:1511-6.
10. Subramanian S, Amonkar MM, Hunt TL. Use of colonoscopy for colorectal cancer screening: evidence from the 2000 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev. 2005;14:409-16.
11. Results are available in an online Appendix, which is available by clicking on the Appendix link in the box to the right of the article online
12. Allison JE, Tekawa IS, Ransom LJ, Adrain AL. A comparison of fecal occult-blood tests for colorectalcancer screening. N Engl J Med. 1996;334:155-9.
13. Ahlquist DA, Wieand HS, Moertel CG, McGill DB, Loprinzi CL, O'Connell MJ, et al. Accuracy of fecal occult blood screening for colorectal neoplasia. JAMA. 1993;269:1262-7.
14. Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME, Colorectal Cancer Study Group. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med. 2004;351:2704-14.
15. Zauber AG, Lansdorp-Vogelaar I, Wilschut J, Knudsen AB, van Ballegooijen M, Kuntz KM. Costeffectiveness of DNA stool testing to screen for colorectal cancer: report to AHRQ and CMS from the Cancer Intervention and Surveillance Modeling Network (CISNET) for MISCAN and SimCRC Models [Internet]. Rockville (MD): Agency for Healthcare Research and Quality; 2007 Dec 20 [cited 2010 Jul 9]. Available from: https://www.cms .gov/determinationprocess/ downloads/id52TA.pdf
16. Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst. 2007;99:1-9.
17. Greenberg PD, Bertario L, Gnauck R, Kronborg O, Hardcastle JD, Epstein MS, et al. A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy. Am J Gastroenterol. 2000; 95:1331-8.
18. Smith A, Young GP, Cole S, Bampton P. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiacbased fecal occult blood test in detection of colorectal neoplasia. Cancer. 107(9):2152-9.
19. Pignone M, Russell L, Wagner J, editors. Economic models of colorectal cancer screening in averagerisk adults: workshop summary. Washington (DC): National Academies Press; 2005.
20. Rex DK, Cutler CS, Lemmel GT, Rahmani EY, Clark DW, Helper DJ, et al. Colonoscopic miss rates of adenomas determined by back-toback colonoscopies. Gastroenterology. 1997;112:24-8.
21. Vijan S, Hwang I, Inadomi J, Wong RK, Choi JR, Napierkowski J, et al. The cost-effectiveness of CT colonography in screening for colorectal neoplasia. Am J Gastroenterol. 2007; 102:380-90.
22. Fisher JA, Fikry C, Troxel AB. Cutting cost and increasing access to colorectal cancer screening: another approach to following the guidelines. Cancer Epidemiol Biomarkers Prev. 2006;15:108-13.
23. Centers for Medicare and Medicaid Services. Medicare program payment under Part B. Fed Regist. 2006;71:69623-70274.
24. Etzioni R, Ramsey SD, Berry K, Brown M. The impact of including future medical care costs when estimating the costs attributable to a disease: a colorectal cancer case study. Health Econ. 2001;10:245-56.
25. Subramanian S, Amonkar MM, Hunt TL. Adherence with colorectal cancer screening guidelines: a review. Prev Med. 2004;38:530-50.
26. Perneger TV, Martin DP, Bovier PA. Physicians' attitudes toward health care rationing. Med Decis Making. 2002;22:65-70.
27. Ubel PA, Baron J, Asch DA. Preference for equity as a framing effect. Med Decis Making. 2001;21(3): 180-9.
28. Benson VS, Patnick J, Davies AK, Nadel MR, Smith RA, Atkin WS. Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int J Cancer. 2008;122: 1357-67.
29. Stalmeier PF, Lamers LM, Busschbach JJ, Krabbe PF. On the assessment of preferences for health and duration: maximal endurable time and better than dead preferences. Med Care. 2007;45:835-41.